101 related articles for article (PubMed ID: 14749701)
1. Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology.
Colvin GA; Lambert JF; Abedi M; Hsieh CC; Carlson JE; Stewart FM; Quesenberry PJ
Leukemia; 2004 Mar; 18(3):575-83. PubMed ID: 14749701
[TBL] [Abstract][Full Text] [Related]
2. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
Robinson S; van Os R; Sheridan T; Mauch P
Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
[TBL] [Abstract][Full Text] [Related]
3. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment.
Rao SS; Peters SO; Crittenden RB; Stewart FM; Ramshaw HS; Quesenberry PJ
Exp Hematol; 1997 Feb; 25(2):114-21. PubMed ID: 9015211
[TBL] [Abstract][Full Text] [Related]
4. Repetitive bone marrow transplantation in nonmyeloablated recipients.
Blomberg M; Rao S; Reilly J; Tiarks C; Peters S; Kittler E; Quesenberry P
Exp Hematol; 1998 Apr; 26(4):320-4. PubMed ID: 9546315
[TBL] [Abstract][Full Text] [Related]
5. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of the engrafting stem cell in mice.
Quesenberry PJ; Becker P; Stewart FM
Stem Cells; 1998; 16 Suppl 1():33-5. PubMed ID: 11012146
[TBL] [Abstract][Full Text] [Related]
7. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells.
El-Badri NS; Wang BY; Cherry ; Good RA
Exp Hematol; 1998 Feb; 26(2):110-6. PubMed ID: 9472800
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
9. Isolation of bone marrow-derived stem cells using density-gradient separation.
Juopperi TA; Schuler W; Yuan X; Collector MI; Dang CV; Sharkis SJ
Exp Hematol; 2007 Feb; 35(2):335-41. PubMed ID: 17258082
[TBL] [Abstract][Full Text] [Related]
10. Engraftment of W/c-kit mutant mice is determined by stem cell competition, not by increased marrow 'space'.
Fleishman RA
Exp Hematol; 1996 Feb; 24(2):209-13. PubMed ID: 8641343
[TBL] [Abstract][Full Text] [Related]
11. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts.
Peters SO; Kittler EL; Ramshaw HS; Quesenberry PJ
Exp Hematol; 1995 May; 23(5):461-9. PubMed ID: 7536685
[TBL] [Abstract][Full Text] [Related]
12. Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: differential activity of cultured bone marrow and enriched stem cell populations.
Knobel KM; McNally MA; Berson AE; Rood D; Chen K; Kilinski L; Tran K; Okarma TB; Lebkowski JS
Exp Hematol; 1994 Dec; 22(13):1227-35. PubMed ID: 7957709
[TBL] [Abstract][Full Text] [Related]
13. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
van Pel M; Hagoort H; Hamann J; Fibbe WE
Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564
[TBL] [Abstract][Full Text] [Related]
14. Improved hematopoietic stem cell engraftment following ex vivo expansion of murine marrow cells with SCF and Flt3L.
Diehl A; Stoelting S; Nadrowitz R; Wagner T; Peters SO
Cytotherapy; 2007; 9(6):532-8. PubMed ID: 17882717
[TBL] [Abstract][Full Text] [Related]
15. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
16. Effects of cytokines on stem cell engraftment depends on time of evaluation post-marrow-infusion.
Peters SO; Habibian HK; Vergilis K; Quesenberry PJ
Int J Hematol; 1999 Aug; 70(2):112-8. PubMed ID: 10497850
[TBL] [Abstract][Full Text] [Related]
17. Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow.
Serrano F; Varas F; Bernad A; Bueren JA
Bone Marrow Transplant; 1994 Dec; 14(6):855-62. PubMed ID: 7711665
[TBL] [Abstract][Full Text] [Related]
18. Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration.
van Os R; Ausema A; Dontje B; van Riezen M; van Dam G; de Haan G
Exp Hematol; 2010 Nov; 38(11):1115-23. PubMed ID: 20643182
[TBL] [Abstract][Full Text] [Related]
19. Primitive stem cells alone mediate rapid marrow recovery and multilineage engraftment after transplantation.
Nibley WE; Spangrude GJ
Bone Marrow Transplant; 1998 Feb; 21(4):345-54. PubMed ID: 9509967
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential.
Traycoff CM; Cornetta K; Yoder MC; Davidson A; Srour EF
Exp Hematol; 1996 Feb; 24(2):299-306. PubMed ID: 8641356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
